Male Sprague-Dawley rats treated daily with GC-1 while being placed on a commercial high-fat diet showed a 75% reduction of hepatic triglyceride content, but developed fasting hyperglycemia and hyperinsulinemia due to increased glucose production and diminished hepatic insulin sensitivity. This evidence concerns the gene INS and Hyperglycemia.